CAR-T Cell Therapy Resource Center
News & Information for Healthcare Professionals
Kite’s CAR T-Cell Therapy Success
March 1, 2017 (The Scientist)
In the 6-month follow-up for a Phase 2 trial focused on 101 advanced non-Hodgkin lymphoma patients who underwent chimeric...
14 scientific definitions for a deeper understanding of CAR-T therapy
Many researchers, oncologists, and pharmaceutical companies hail CAR-T therapy as a “cure for cancer.” But what exactly is this evolving technology? How is it...
VIDEO: Interview with Arie Belldegrun, Kite Pharma CEO on pricing
October 17, 2016 (CNBC)
Arie Belldegrun, Kite Pharma CEO talks to CNBC's Meg Tirrell about developing cancer immunotherapy drugs with T-cells. Also Belldegrun address the...
Immune cell therapy shows promising results for lymphoma patients
January 5, 2017 (ScienceDaily.com)
Lymphoma, the most common blood cancer, is the result of the uncontrollable multiplication of lymphocytes (immune cells). B-cell lymphomas account...
StatPearls Question of the Week – #5
In the recent clinical trials involving Chimeric Antigen Receptor T cell therapy (CAR-T), which complication led to a halt in the studies?
A. Myocardial...
Targeting Adenosine 2A Receptors Enhances CAR T-Cell Efficacy
February 6, 2017 (The Journal of Clinical Investigation)
Part of the reason why treatment of solid tumors using CAR T-cells has been troublesome is because...
Universal CAR T-Cell Therapy Helped Treat ALL in Two Infants
January 26, 2017 (HealthDay News)
Modified T cells from healthy donor allowed infants to reach remission, researchers report
Two infants with B-cell acute lymphoblastic leukemia (ALL)...
Antibody That Precisely Targets T Cells Discovered
May 22, 2017 (Medical News Today)
An antibody originally developed to study multiple sclerosis has been found to precisely target T cells that can kill...
StatPearls Question of the Week – #4
On which malignancies is Chimeric Antigen Receptor T-cell therapy (CAR-T) being tested?
A. Solid tumors
B. Hematological malignancies
C. Sarcomas
D. Skin cancers
Click...
CAR-T Cell Therapy HCP Guide – KTE-C19 Studies – Zuma 6 Trials
CAR T-Cell Therapy and Checkpoint Inhibitors Together?
CAR T-cell therapy positive response rates in aggressive leukemias and lymphomas are impressive, but relapse or progression does...
